-
HEALWELL's DARWEN(TM) AI Outperforms Published Foundation Model Benchmarks and Demonstrates Real-World Patient Impact in New Peer-Reviewed Research
-
Healwell's Darwen AI to match clinical trials to 100K+ consented patients
-
WELL Health Announces WELLTRUST(TM) Surpasses 100,000 Patient Consents
-
HEALWELL's DARWEN(TM) to Power AI-Driven Clinical Trial Matching for WELLTRUST(TM), a Network of Over 100,000 Consented Patients
-
HEALWELL to Deploy AI-Powered SMART Search and SMART Summary Across Statewide U.S. Health Information Exchange
-
20/20 BioLabs meets with East Asia partners to explore expansion
-
20/20 BioLabs reaches standstill deal on Series E preferred stock
-
20/20 BioLabs reports Q2 revenue growth, outlines Medicare strategy
-
20/20 Biolabs prepares contingency plans for Ebola and Hantavirus testing
-
Maxim Group Starts 20/20 Biolabs (AIDX) at Buy
-
BIO-key International, 20/20 Biolabs, Society Pass, and Soligenix Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
20/20 BioLabs begins trading on NASDAQ under ticker AIDX


